Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 46,520	$ 91,542
Restricted cash	5,097	7,565
Inventories	570,653	581,384
Prepaid expenses and other current assets	87,298	82,685
Total current assets	1,380,044	1,377,863
Property, plant and equipment, net	439,815	447,574
Goodwill	598,549	598,629
Intangible assets, net	859,272	890,423
Other assets	73,747	55,517
Total assets	3,456,397	3,472,569
Current liabilities:
Current portion of liabilities for legal matters	30,130	76,988
Revolving credit facility	179,000	179,000
Current portion of long-term debt, net	33,660	34,125
Total current liabilities	834,388	846,595
Long-term debt, net	2,377,707	2,386,004
Note payable - related party	41,893	41,447
Liabilities for legal matters - long term	85,479	316
Total long-term liabilities	2,638,616	2,564,670
Commitments and contingencies (Notes 4 and 17)
Redeemable non-controlling interests	47,022	41,293
Stockholders' (Deficiency) Equity
Preferred stock, $0.01 par value, 2,000 shares authorized at both March 31, 2024 and December 31, 2023; none issued at both March 31, 2024 and December 31, 2023	0	0
Additional paid-in capital	538,720	539,240
Stockholders' accumulated deficit	(581,819)	(490,176)
Accumulated other comprehensive loss	(23,711)	(32,349)
Total Amneal Pharmaceuticals, Inc. stockholders' (deficiency) equity	(63,724)	19,781
Non-controlling interests	95	230
Total stockholders' (deficiency) equity	(63,629)	20,011
Total liabilities and stockholders' (deficiency) equity	3,456,397	3,472,569
Related Party
Current assets:
Trade accounts receivable, net	1,521	955
Operating lease right-of-use assets	12,468	12,954
Current liabilities:
Accounts payable and accrued expenses	17,075	7,321
Current portion of operating lease liabilities - related party	3,192	2,825
Operating lease liabilities	11,969	12,787
Other long-term liabilities	11,394	11,776
Nonrelated Party
Current assets:
Trade accounts receivable, net	668,955	613,732
Operating lease right-of-use assets	32,970	30,329
Financing lease right-of-use assets	59,532	59,280
Current liabilities:
Accounts payable and accrued expenses	558,518	534,662
Current portion of operating lease liabilities	9,508	9,207
Current portion of financing lease liabilities	3,305	2,467
Operating lease liabilities	26,786	24,095
Financing lease liabilities	58,809	58,566
Other long-term liabilities	24,579	29,679
Common Class A
Stockholders' (Deficiency) Equity
Common stock	3,086	3,066
Common Class B
Stockholders' (Deficiency) Equity
Common stock	$ 0	$ 0